Mizuho Initiates Coverage On Terns Pharma with Buy Rating, Announces Price Target of $16
Portfolio Pulse from richadhand@benzinga.com
Mizuho analyst Graig Suvannavejh initiates coverage on Terns Pharma (NASDAQ:TERN) with a Buy rating and announces a price target of $16.
June 22, 2023 | 9:42 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho initiates coverage on Terns Pharma with a Buy rating and a price target of $16.
Mizuho's initiation of coverage on Terns Pharma with a Buy rating and a price target of $16 indicates a positive outlook for the stock. This news is likely to attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100